{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:14:02Z","timestamp":1771017242455,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":670,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1111\/bjd.12544","type":"journal-article","created":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T09:55:25Z","timestamp":1375437325000},"page":"1133-1140","source":"Crossref","is-referenced-by-count":21,"title":["Interferon-\u03b3 release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists:<i>in vivo<\/i>and<i>in vitro<\/i>analysis"],"prefix":"10.1093","volume":"169","author":[{"given":"I.","family":"Sauzullo","sequence":"first","affiliation":[{"name":"Department of Public Health and Infectious Diseases; Sapienza University; Piazzale Aldo Moro 1 00185 Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mengoni","sequence":"additional","affiliation":[{"name":"Department of Public Health and Infectious Diseases; Sapienza University; Piazzale Aldo Moro 1 00185 Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Marocco","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit; Fondazione Eleonora Lorillard Spencer Cenci; Sapienza University; Latina Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Potenza","sequence":"additional","affiliation":[{"name":"Dermatology Unit; Polo Pontino; Terracina Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Skroza","sequence":"additional","affiliation":[{"name":"Dermatology Unit; Polo Pontino; Terracina Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Tieghi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit; Fondazione Eleonora Lorillard Spencer Cenci; Sapienza University; Latina Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lichtner","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit; Fondazione Eleonora Lorillard Spencer Cenci; Sapienza University; Latina Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Vullo","sequence":"additional","affiliation":[{"name":"Department of Public Health and Infectious Diseases; Sapienza University; Piazzale Aldo Moro 1 00185 Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Mastroianni","sequence":"additional","affiliation":[{"name":"Department of Public Health and Infectious Diseases; Sapienza University; Piazzale Aldo Moro 1 00185 Rome Italy"},{"name":"Infectious Diseases Unit; Fondazione Eleonora Lorillard Spencer Cenci; Sapienza University; Latina Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,10,31]]},"reference":[{"key":"10.1111\/bjd.12544-BIB0001|bjd12544-cit-0001","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis - epidemiology and clinical spectrum","volume":"26","author":"Christophers","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12544-BIB0002|bjd12544-cit-0002","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1111\/bjd.12544-BIB0003|bjd12544-cit-0003","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-065X.2008.00702.x","article-title":"The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis","volume":"226","author":"Cooper","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1111\/bjd.12544-BIB0004|bjd12544-cit-0004","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management","volume":"3","author":"Gardam","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/bjd.12544-BIB0005|bjd12544-cit-0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaad.2008.05.033","article-title":"Tuberculosis in the age of biologic therapy","volume":"59","author":"Hernandez","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12544-BIB0006|bjd12544-cit-0006","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaad.2008.03.023","article-title":"National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents","volume":"59","author":"Doherty","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12544-BIB0007|bjd12544-cit-0007","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/bjd.12544-BIB0008|bjd12544-cit-0008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000222431","article-title":"Tuberculin skin test overestimates tuberculosis hypersensitivity in adult patients with psoriasis","volume":"219","author":"Tsiouri","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/bjd.12544-BIB0009|bjd12544-cit-0009","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1378\/chest.06-2471","article-title":"Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy","volume":"131","author":"Lalvani","year":"2007","journal-title":"Chest"},{"key":"10.1111\/bjd.12544-BIB0010|bjd12544-cit-0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1111\/bjd.12544-BIB0011|bjd12544-cit-0011","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2133.2009.09331.x","article-title":"Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-\u03b3 release assay vs. tuberculin skin test","volume":"161","author":"Laffitte","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12544-BIB0012|bjd12544-cit-0012","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1365-2133.2008.08457.x","article-title":"QuantiFERON-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor alpha therapy","volume":"158","author":"Desai","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12544-BIB0013|bjd12544-cit-0013","first-page":"553","article-title":"Clinical experience of QuantiFERON-TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan","volume":"164","author":"Chiu","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12544-BIB0014|bjd12544-cit-0014","doi-asserted-by":"crossref","first-page":"381929","DOI":"10.1155\/2012\/381929","article-title":"Immunosuppression adversely affects TST but not IGRAs in patients with psoriasis or inflammatory musculoskeletal diseases","volume":"2012","author":"Tavast","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1111\/bjd.12544-BIB0015|bjd12544-cit-0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10238-012-0192-7","article-title":"Negative effect of immunosuppressive therapy in the performance of the QuantiFERON Gold In-Tube test in patients with immune-mediated inflammatory diseases","volume":"13","author":"Ramos","year":"2013","journal-title":"Clin Exp Med"},{"key":"10.1111\/bjd.12544-BIB0016|bjd12544-cit-0016","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1468-3083.2011.04220.x","article-title":"Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-\u03b1 treatment: a prospective, observational study","volume":"26","author":"Garcovich","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12544-BIB0017|bjd12544-cit-0017","first-page":"84","article-title":"T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India","volume":"13","author":"Pai","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/bjd.12544-BIB0018|bjd12544-cit-0018","unstructured":"AbbVie Inc Humira prescribing information http:\/\/www.rxabbott.com\/pdf\/humira.pdf"},{"key":"10.1111\/bjd.12544-BIB0019|bjd12544-cit-0019","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00063030-200418020-00005","article-title":"Adalimumab: a review of its use in rheumatoid arthritis","volume":"18","author":"Bang","year":"2004","journal-title":"BioDrugs"},{"key":"10.1111\/bjd.12544-BIB0020|bjd12544-cit-0020","first-page":"S140","article-title":"Pharmacokinetic\/pharmacodynamic (PK\/PD) relationships of adalimumab (HUMIRA, Abbott) in rheumatoid arthritis (RA) patients during phase II\/III clinical trials","volume":"48","author":"Granneman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1111\/bjd.12544-BIB0021|bjd12544-cit-0021","first-page":"834","article-title":"Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumor necrosis factor-alpha treatment","volume":"14","author":"Sauzullo","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/bjd.12544-BIB0022|bjd12544-cit-0022","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s10067-012-2049-6","article-title":"Serial interferon-\u03b3 release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents","volume":"31","author":"Scrivo","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1111\/bjd.12544-BIB0023|bjd12544-cit-0023","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3899\/jrheum.120688","article-title":"Mycobacterial IFN-\u03b3 release variations during long-term treatment with tumor necrosis factor blockers: lack of correlation with clinical outcome","volume":"40","author":"Scrivo","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1111\/bjd.12544-BIB0024|bjd12544-cit-0024","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/rheumatology\/keh464","article-title":"Update on the British Society for Rheumatology guidelines for prescribing TNF\u03b1 blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)","volume":"44","author":"Ledingham","year":"2005","journal-title":"Rheumatology"},{"key":"10.1111\/bjd.12544-BIB0025|bjd12544-cit-0025","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1183\/09031936.00117506","article-title":"Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay","volume":"29","author":"Leyten","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1111\/bjd.12544-BIB0026|bjd12544-cit-0026","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.tube.2011.05.004","article-title":"Influence of previous tuberculin skin test on serial IFN-\u03b3 release assays","volume":"91","author":"Sauzullo","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1111\/bjd.12544-BIB0027|bjd12544-cit-0027","first-page":"1146","article-title":"Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis","volume":"12","author":"Katiyar","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/bjd.12544-BIB0028|bjd12544-cit-0028","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/381754","article-title":"Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy","volume":"38","author":"Carrara","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/bjd.12544-BIB0029|bjd12544-cit-0029","doi-asserted-by":"crossref","first-page":"e5187","DOI":"10.1371\/journal.pone.0005187","article-title":"In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response","volume":"4","author":"Sauzullo","year":"2009","journal-title":"PLoS One"},{"key":"10.1111\/bjd.12544-BIB0030|bjd12544-cit-0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1745-6673-1-7","article-title":"Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report","volume":"1","author":"Pai","year":"2006","journal-title":"J Occup Med Toxicol"},{"key":"10.1111\/bjd.12544-BIB0031|bjd12544-cit-0031","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1440-1843.2008.01244.x","article-title":"Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis","volume":"13","author":"Higuchi","year":"2008","journal-title":"Respirology"},{"key":"10.1111\/bjd.12544-BIB0032|bjd12544-cit-0032","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1038\/ajg.2009.322","article-title":"Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease","volume":"104","author":"Marehbian","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/bjd.12544-BIB0033|bjd12544-cit-0033","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2036.2006.02786.x","article-title":"Review article: infliximab therapy for inflammatory bowel disease - seven years on","volume":"3","author":"Rutgeers","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/bjd.12544-BIB0034|bjd12544-cit-0034","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/annrheumdis-2011-200489","article-title":"Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNF\u03b1 inhibitors: the utility of IFN\u03b3 assay","volume":"71","author":"Chen","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/bjd.12544-BIB0035|bjd12544-cit-0035","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1378\/chest.07-2193","article-title":"The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection","volume":"133","author":"Choi","year":"2008","journal-title":"Chest"},{"key":"10.1111\/bjd.12544-BIB0036|bjd12544-cit-0036","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pone.0000183","article-title":"Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts","volume":"2","author":"Hill","year":"2007","journal-title":"PLoS One"},{"key":"10.1111\/bjd.12544-BIB0037|bjd12544-cit-0037","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1183\/09031936.00017807","article-title":"Evidence for boosting Mycobacterium tuberculosis-specific IFN-gamma responses at 6\u00a0weeks following tuberculin skin testing","volume":"29","author":"Naseer","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1111\/bjd.12544-BIB0038|bjd12544-cit-0038","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1371\/journal.pmed.0040192","article-title":"Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection","volume":"4","author":"Hill","year":"2007","journal-title":"PLOS Med"},{"key":"10.1111\/bjd.12544-BIB0039|bjd12544-cit-0039","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1164\/rccm.200511-1783OC","article-title":"Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis","volume":"174","author":"Ewer","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/bjd.12544-BIB0040|bjd12544-cit-0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/rccm.200604-472OC","article-title":"Serial testing of health care workers for tuberculosis using interferon-gamma assay","volume":"174","author":"Pai","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/bjd.12544-BIB0041|bjd12544-cit-0041","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/CVI.00398-07","article-title":"Reproducibility of QuantiFERON-TB gold in-tube assay","volume":"15","author":"Perry","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1111\/bjd.12544-BIB0042|bjd12544-cit-0042","doi-asserted-by":"crossref","first-page":"e1850","DOI":"10.1371\/journal.pone.0001850","article-title":"T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data","volume":"3","author":"Veerapathran","year":"2008","journal-title":"PLoS One"},{"key":"10.1111\/bjd.12544-BIB0043|bjd12544-cit-0043","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/670635","article-title":"A summary of meeting proceedings on addressing variability around the cut point in serial interferon-\u03b3 release assay testing","volume":"34","author":"Daley","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/bjd.12544-BIB0044|bjd12544-cit-0044","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar1994","article-title":"Inhibition of antituberculosis T-lymphocyte function with tumour necrosis factor antagonists","volume":"8","author":"Hamdi","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/bjd.12544-BIB0045|bjd12544-cit-0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay","volume":"67","author":"Matulis","year":"2008","journal-title":"Ann Rheum Dis"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12544","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12544\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T23:06:15Z","timestamp":1715814375000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/169\/5\/1133\/6615289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,31]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12544","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10,31]]}}}